Urist Marshall
EVP, Research & Investments
Urist Marshall has filed 20 SEC Form 4 filings (23 transaction rows) across 1 company, with disclosures dating back to 2025. 20 of those filings fall inside the rolling window. Most recent filing: Oct 5, 2026.
On the most recent filing, Urist Marshall is listed as EVP, Research & Investments at Royalty Pharma plc. Inside the rolling window, Urist Marshall reported no open-market purchases and 16 open-market sales totaling $12.5M in RPRX. The largest disclosed transaction in the window is a sale of 41,575 RPRX shares on Dec 1, 2025, worth $1.7M.
Companies traded
Other insiders at RPRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$12.5M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| RPRX | EVP, Research & Investments | Sale | 4,126 | $236K | Oct 5 | SEC ↗ | |
| RPRX | EVP, Research & Investments | Sale | 4,126 | $239K | Sep 30 | SEC ↗ | |
| RPRX | EVP, Research & Investments | Sale | 9,099 | $508K | Jul 2 | SEC ↗ | |
| RPRX | EVP, Research & Investments | Sale | 9,098 | $502K | Jun 25 | SEC ↗ | |
| RPRX | EVP, Research & Investments | Sale | 13,684 | $722K | May 22 | SEC ↗ | |
| RPRX | EVP, Research & Investments | Sale | 13,684 | $726K | May 15 | SEC ↗ | |
| RPRX | EVP, Research & Investments | Sale | 20,000 | $822K | Feb 2 | SEC ↗ | |
| RPRX | EVP, Research & Investments | Sale | 20,000 | $805K | Jan 26 | SEC ↗ | |
| RPRX | EVP, Research & Investments | Sale | 20,000 | $790K | Jan 20 | SEC ↗ | |
| RPRX | EVP, Research & Investments | Sale | 20,000 | $816K | Jan 13 | SEC ↗ | |
| RPRX | EVP, Research & Investments | Sale | 20,000 | $770K | Jan 6 | SEC ↗ | |
| RPRX | EVP, Research & Investments | Sale | 20,000 | $786K | Dec 29 | SEC ↗ | |
| RPRX | EVP, Research & Investments | Sale | 20,000 | $768K | Dec 22 | SEC ↗ | |
| RPRX | EVP, Research & Investments | Sale | 20,000 | $766K | Dec 17 | SEC ↗ | |
| RPRX | EVP, Research & Investments | Sale | 41,576 | $1.6M | Dec 9 | SEC ↗ | |
| RPRX | EVP, Research & Investments | Sale | 41,575 | $1.7M | Dec 3 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 filings has Urist Marshall made?
Urist Marshall has filed 20 SEC Form 4 filings (23 transaction rows) across 1 company since 2025.
Which companies does Urist Marshall trade?
Urist Marshall has filed SEC Form 4 disclosures for 1 company, including RPRX.
When was Urist Marshall's most recent SEC Form 4 filing?
Urist Marshall's most recent SEC Form 4 filing on Tracefour is dated Oct 5, 2026.
What is Urist Marshall's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Urist Marshall is listed as EVP, Research & Investments.
What is Urist Marshall's total buy and sell value in the current window?
Inside the rolling retention window, Urist Marshall bought $0 and sold $12.5M based on SEC Form 4 filings.
What was Urist Marshall's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 41,575 RPRX shares on 2025-12-01, worth $1.7M, per SEC Form 4 filings.